Mererid Evans
Papers
2
Total Citations
34
H-Index
2
About
Dr. Mererid Evans is a leading clinical researcher in head and neck oncology, with a primary focus on human papillomavirus (HPV)-positive oropharyngeal cancer. Her work is at the forefront of a critical shift in treatment: de-escalating therapy to reduce long-term toxicities while maintaining excellent survival rates. She is best known for her leadership in the landmark **PATHOS trial** (cited 18 times), a phase II/III study that pioneered risk-stratified, reduced-intensity adjuvant treatment following transoral surgery for HPV-positive patients. This work directly addresses the growing challenge of managing treatment side effects in a younger, healthier patient population. More recently, Dr. Evans has investigated surgical techniques, comparing transoral robotic surgery (TORS) and transoral laser microsurgery (TLM) in a 2024 study (16 citations), finding that TORS may offer superior margin clearance. Her research is instrumental in shaping modern, de-escalated treatment paradigms, ensuring that patients not only survive but thrive after cancer therapy. Dr. Evans’ contributions are vital for any student or researcher interested in precision oncology, surgical innovation, and improving quality of life in cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma16 citations · 2024